title: Editorial comment.
authors.affiliation: aDepartment of Urology, UT Southwestern Medical Center at Dallas, Dallas, Texas, USA bDirektor der Klinik und Poliklinik für Urologie Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
authors.forename: Yair
authors.initials: Y
authors.lastname: Lotan
authors.forename: Axel S
authors.initials: AS
authors.lastname: Merseburger
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D044127:Epigenesis, Genetic; D023281:Genomics / Q000379:methods; D006801:Humans; D057285:Precision Medicine / Q000379:methods; D035583:Rare Diseases / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D014571:Urologic Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor